Transmedics Group Inc
NASDAQ:TMDX

Watchlist Manager
Transmedics Group Inc Logo
Transmedics Group Inc
NASDAQ:TMDX
Watchlist
Price: 73.11 USD 7.09% Market Closed
Market Cap: 2.5B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one TMDX stock under the Base Case scenario is 42.39 USD. Compared to the current market price of 73.11 USD, Transmedics Group Inc is Overvalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TMDX Relative Value
Base Case
42.39 USD
Overvaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.6
P/S
P/S
Price to Sales
5.6
vs History
93
vs Industry
25
Median 3Y
15
Median 5Y
17.4
Industry
2.2
Forward
4.4
More Details
69.3
P/E
P/E
Price to Earnings
69.3
vs History
11
vs Industry
7
Median 3Y
-34.7
Median 5Y
-20.8
Industry
22.5
Forward
48.9
More Details
50.4
P/OCF
P/OCF
Price to OCF
50.4
vs History
11
vs Industry
6
Median 3Y
-33.4
Median 5Y
-24.2
Industry
13.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
26
Median 3Y
-22.8
Median 5Y
-21.1
Industry
19.7
More Details
10.8
P/B
P/B
Price to Book Value
10.8
vs History
52
vs Industry
5
Median 3Y
13.9
Median 5Y
10.5
Industry
2.1
More Details
6
EV/S
EV/S
Enterprise Value to Sales
6
vs History
93
vs Industry
21
Median 3Y
14.5
Median 5Y
15.6
Industry
2.3
Forward
4.8
More Details
10
EV/GP
EV/GP
Enterprise Value to Gross Profit
10
vs History
93
vs Industry
22
Median 3Y
23
Median 5Y
23.6
Industry
4.9
More Details
45.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
45.9
vs History
15
vs Industry
6
Median 3Y
-28.6
Median 5Y
-18.6
Industry
11.9
Forward
26.6
More Details
70.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
70.2
vs History
11
vs Industry
5
Median 3Y
-36.5
Median 5Y
-21.2
Industry
16.4
Forward
43.1
More Details
53.9
EV/OCF
EV/OCF
Enterprise Value to OCF
53.9
vs History
11
vs Industry
6
Median 3Y
-32.9
Median 5Y
-21.4
Industry
13.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-25.6
Median 5Y
-21.6
Industry
17.2
More Details
5.8
EV/IC
EV/IC
Enterprise Value to IC
5.8
vs History
92
vs Industry
14
Median 3Y
13.5
Median 5Y
16.3
Industry
1.8
More Details

Multiples Across Competitors

TMDX Competitors Multiples
Transmedics Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Transmedics Group Inc
NASDAQ:TMDX
2.5B USD 5.6 69.3 45.9 70.2
US
Abbott Laboratories
NYSE:ABT
228.5B USD 5.4 17 22.8 33.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.6B USD 21.6 77.8 60.3 73.1
US
Boston Scientific Corp
NYSE:BSX
147.4B USD 8.8 79.5 36.4 51.3
US
Stryker Corp
NYSE:SYK
144B USD 6.4 48.1 24.9 30.1
IE
Medtronic PLC
NYSE:MDT
114B USD 3.4 26.8 14.2 20.1
US
Becton Dickinson and Co
NYSE:BDX
65.4B USD 3.2 37.4 15.6 28.1
DE
Siemens Healthineers AG
XETRA:SHL
56.1B EUR 2.5 28.2 16.2 23.1
US
Edwards Lifesciences Corp
NYSE:EW
42.3B USD 7.8 10.1 23.8 26.3
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
278.7B CNY 7.5 22.5 19.6 19.6
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.2B USD 1.8 18.2 12.7 15.6

See Also

Summary
TMDX intrinsic value, competitors valuation, and company profile.
DCF Valuation
TMDX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TMDX stock valuation using valuation multiples.
Wall Street Estimates
TMDX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TMDX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 243,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.